Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
22.36
-0.28 (-1.24%)
At close: Oct 22, 2024, 4:00 PM
22.12
-0.24 (-1.07%)
After-hours: Oct 22, 2024, 4:00 PM EDT
Pharvaris Employees
Pharvaris had 82 employees as of December 31, 2023. The number of employees increased by 17 or 26.15% compared to the previous year.
Employees
82
Change (1Y)
17
Growth (1Y)
26.15%
Revenue / Employee
n/a
Profits / Employee
-$1,490,856
Market Cap
1.21B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 82 | 17 | 26.15% |
Dec 31, 2022 | 65 | 31 | 91.18% |
Dec 31, 2021 | 34 | 20 | 142.86% |
Dec 31, 2020 | 14 | 11 | 366.67% |
Dec 31, 2019 | 3 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Brookdale Senior Living | 36,000 |
U.S. Physical Therapy | 6,720 |
agilon health | 1,117 |
CareDx | 643 |
ANI Pharmaceuticals | 642 |
Gyre Therapeutics | 593 |
Autolus Therapeutics | 471 |
Collegium Pharmaceutical | 197 |
PHVS News
- 7 days ago - Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings - GlobeNewsWire
- 8 days ago - Pharvaris to Host Virtual Investor Event on October 23, 2024 - GlobeNewsWire
- 20 days ago - Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop - GlobeNewsWire
- 6 weeks ago - Pharvaris Provides Business Update and Expands Development Program for Deucrictibant - GlobeNewsWire
- 6 weeks ago - Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 - GlobeNewsWire
- 6 weeks ago - Pharvaris Presents Data at the Bradykinin Symposium 2024 - GlobeNewsWire
- 2 months ago - Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium - GlobeNewsWire
- 2 months ago - Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire